You are here

Article metrics

Article menu
Download PDFPDF
Editorial commentary
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy

 

Online download statistics by month:

Online download statistics by month: August 2017 to September 2024

AbstractFullPdf
Aug 20177323829
Sep 20171791016
Oct 201710498
Nov 20173192623
Dec 20173856226
Jan 20181771516
Feb 20181111111
Mar 2018144614
Apr 20187659
May 2018119812
Jun 2018105510
Jul 201810138
Aug 201810069
Sep 2018971011
Oct 20187928
Nov 20189439
Dec 20186825
Jan 20195164
Feb 20196246
Mar 20196745
Apr 20196228
May 20195867
Jun 20195638
Jul 20197735
Aug 20194613
Sep 20195035
Oct 20196806
Nov 20194347
Dec 20195103
Jan 20206107
Feb 20203222
Mar 20205214
Apr 20205553
May 20203302
Jun 20204947
Jul 20203921
Aug 20201523
Sep 20205823
Oct 20203114
Nov 2020101310
Dec 20202403
Jan 20215144
Feb 202166213
Mar 20214115
Apr 20214729
May 20212415
Jun 2021415
Jul 2021532
Aug 2021314
Sep 2021653
Oct 20213404
Nov 20213130
Dec 20215258
Jan 20222911
Feb 202213934
Mar 20224612
Apr 20223534
May 20225903
Jun 20224951
Jul 20223343
Aug 20228231
Sep 20223900
Oct 20225723
Nov 20223603
Dec 20222503
Jan 2023914
Feb 202312622
Mar 20232512
Apr 2023710
May 20232803
Jun 20231111
Jul 20232901
Aug 20232422
Sep 20232001
Oct 20232915
Nov 20232221
Dec 20236724
Jan 20243302
Feb 20245011
Mar 20245004
Apr 20245543
May 20246035
Jun 20242902
Jul 20243300
Aug 20246605
Sep 20241810
Total6015351478